| Added by | mollevi |
|---|---|
| Group name | EquipeMY |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: a IRCM; Institut de Recherche en Cancerologie de Montpellier ; Montpellier ; France. alt-title: mAbs number: 5 accession-num: 25517316 |
| Tags | _EndnoteXML import |
| Date Added | 2019/05/22 - 09:42:41 |
| Date Modified | 2019/05/22 - 09:42:41 |
| Parent item | The human Mullerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4 |
Institut de Recherche en Cancérologie de
